Article
Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Antimicrobial agents and chemotherapy - 1 Nov 1996
Moghazeh S L, Pan X, Arain T, Stover C K, Musser J M, Kreiswirth B N
Abstract excerpt
A collection of 24 rifampin-resistant clinical isolates of Mycobacterium tuberculosis with characterized RNA polymerase beta-subunit (rpoB) gene mutations was tested against the antimycobacterial agents rifampin, rifapentine, and KRM-1648 to correlate levels of resistance with specific rpoB genot...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.